Vol. 28.Issue. 4. July - August 2023 | Annals of Hepatology

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Buscar en

Annals of Hepatology

Toda la web

Inicio Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2022

3.8

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2022

6.3

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2022

0.859

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2022

0.989

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 28. Issue 4.

(July - August 2023)

Editorial board

Ann Hepatol. 2023;28:101131

Full text access

Editorial

A call for unity: The path towards a more precise and patient-centric nomenclature for NAFLD

Ann Hepatol. 2023;28:101115

Full text access

Shutting those revolving doors

Amedeo Lonardo

Ann Hepatol. 2023;28:101106

Full text access

Opinions

The leading and key role of hepatologists in the multidisciplinary management of patients with hepatocellular carcinoma

Juan Ignacio Marín, Margarita Anders, Aline Chagas, Josemaría Menéndez, Oscar Beltran, Enrique Carrera Estupiñan, Javier Diaz Ferrer, Angelo A. Mattos, ... special group of interest of liver cancer from the American Association Study for Liver Diseases (ALEH)

Ann Hepatol. 2023;28:101112

Full text access

Original articles

Comparison of diagnostic performance of AFP, DCP and two diagnostic models in hepatocellular carcinoma: a retrospective study

Yongwu Chen, Xiuli Yang, Yanfei Shao, Hongying Zhao, Jinying Jiang, Ping Huang, Yi Lu, Zixue Xuan

Ann Hepatol. 2023;28:101099

Full text access

Early living donor liver transplantation for alcohol-associated hepatitis

Anand V. Kulkarni, Raghuram Reddy, Juan Pablo Arab, Mithun Sharma, Sameer Shaik, Sowmya Iyengar, Naveen Kumar, , ... K. Rajender Reddy

Ann Hepatol. 2023;28:101098

Full text access

Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay

Carolina Vazquez, María Nelly Gutierrez-Acevedo, Sabrina Barbero, Lorena del Carmen Notari, Marina Agozino, José Luis Fernandez, María Margarita Anders, Nadia Lorena Grigera, ... Sebastián Marciano

Ann Hepatol. 2023;28:101097

Full text access

Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome

Michelle Harriz Braga, Guilherme Grossi Lopes Cançado, Paulo Lisboa Bittencourt, Cláudia Alves Couto, Laura Vilar Guedes, André Mourão Costa Lima, Maria Lucia Gomes Ferraz, Cristiane Alves Villela-Nogueira, ... Members of the Brazilian Cholestasis Study Group Consortium

Ann Hepatol. 2023;28:101105

Full text access

Systematic review and meta-analysis: Transient elastography compared to liver biopsy for staging of liver fibrosis in primary biliary cholangitis

Luis Antonio Manzo-Francisco, Jorge Aquino-Matus, Dèsirée Vidaña-Pérez, Misael Uribe, Norberto Chavez-Tapia

Ann Hepatol. 2023;28:101107

Full text access

Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study

Ke Su, Qiuni Shen, Jian Tong, Tao Gu, Ke Xu, Han Li, Hao Chi, Yanlin Liu, ... Yunwei Han

Ann Hepatol. 2023;28:101109

Full text access

Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC

Federico Piñero, Margarita Anders, Carla Bermudez, Ezequiel Demirdjian, Adriana Varón, Ana Palazzo, Jorge Rodriguez, Oscar Beltrán, ... Manuel Mendizabal

Ann Hepatol. 2023;28:101110

Full text access

Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)

James M. Paik, Katherine E Eberly, Khaled Kabbara, Michael Harring, Youssef Younossi, Linda Henry, Manisha Verma, Zobair M. Younossi

Ann Hepatol. 2023;28:101108

Full text access

Prevalence of non-alcoholic fatty liver disease and liver fibrosis in a general population cohort from Argentina

Federico Guillermo Villamil, Manuel Barbero, Nancy Elena Massenzio, Sandra Mónica Giani, Shigeru Kozima, Fernando Mario Cairo, Rodrigo Agustín Belloni, Javier Mariani, ... Patricia Eugenia Gallardo

Ann Hepatol. 2023;28:101111

Full text access

Letters to the editor

Comment on “Type 2 Diabetes Complications are Associated with Liver Fibrosis Independent of Hemoglobin A1c”

Zhenjing Wang, Nai Liu, Caixia Guo

Ann Hepatol. 2023;28:101113

Full text access

Reply to: Type 2 Diabetes Complications are Associated with Liver Fibrosis Independent of Hemoglobin A1c

Hirsh D. Trivedi, Michelle Lai

Ann Hepatol. 2023;28:101114

Full text access

Special issue on genomic medicine in obesity and chronic liver damage

Prevalence of liver cirrhosis based on the metabolic health and weight criteria: Report from the Korea National Health and Nutrition Examination Survey (KNHANES) data analysis

Hyukjin Mun, Eun Sun So

Ann Hepatol. 2023;28:100721

Full text access

Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease

Dongna Zhao, Haozhe Cui, Zhiqiang Shao, Liying Cao

Ann Hepatol. 2023;28:100726

Full text access

Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents

Diego García-Compeán, Ramesh Kumar, Ángel Noe del Cueto-Aguilera, Héctor Jesús Maldonado-Garza, Jesús Zacarías Villarreal-Pérez

Ann Hepatol. 2023;28:100751

Full text access

Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action

Alexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman

Ann Hepatol. 2023;28:100766

Full text access

Late evening snack and oral amino acid capsules improved respiratory quotient and Fischer ratio in patients with alcoholic liver cirrhosis

Juan Zhao, Jing Wu, Juan Li, Zhong-Ying Wang, Qing-Hua Meng

Ann Hepatol. 2023;28:100750

Full text access